Company Filing History:
Years Active: 2022-2023
Title: Elsa Beyer Krall: Innovator in Cancer Research
Introduction
Elsa Beyer Krall is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of cancer research through her innovative work and patented inventions. With a focus on developing compounds that inhibit specific proteins, her research aims to provide new therapeutic options for cancer treatment.
Latest Patents
Elsa Beyer Krall holds 2 patents related to her groundbreaking work. Her latest patents include the development of substituted pyrazolopyrimidines and substituted purines, which serve as inhibitors of ubiquitin-specific-processing protease 1 (USP1). These compounds are designed to inhibit USP1 proteins and treat disorders that respond to USP1 inhibition, particularly in cancer therapy. The detailed specifications of these compounds highlight their potential as effective treatments for various types of cancer.
Career Highlights
Throughout her career, Elsa has demonstrated a commitment to advancing cancer research. Her work at Ksq Therapeutics, Inc. has positioned her as a key player in the development of novel therapeutic agents. Her innovative approach and dedication to research have garnered attention in the scientific community.
Collaborations
Elsa has collaborated with notable colleagues, including Jehrod Burnett Brenneman and Michael R Schlabach. These partnerships have further enhanced her research efforts and contributed to the success of her projects.
Conclusion
Elsa Beyer Krall is a distinguished inventor whose work in cancer research has the potential to transform treatment options. Her innovative patents and collaborations reflect her dedication to improving patient outcomes through scientific advancement.